Michael is a biomedical engineer and economist. He is currently working as a Global BI manager within the divisional strategy team of Sandoz International in Germany. Amidst his responsibilities, Michael is advising on key strategic projects to support the execution of the Sandoz transformation program. Prior to joining Sandoz, Michael worked in life sciences consulting in London where he specialized in digital health and growth strategy.

What is the pop up in your job?

• What drives me is the diversity of content and people I get to work with every day, as well as the intellectual challenges that the job poses.  Ultimately, I am passionate about Sandoz’ mission, which is to make medicines more accessible across the world.

 

Sandoz is a global leader in generic pharmaceuticals and biosimilars. As a division of the Novartis Group, our purpose is to discover new ways to improve and extend people's lives. We contribute to society's ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine. Our portfolio of approximately 1,000 molecules, covering all major therapeutic areas, accounted for 2017 sales of USD 10.1 billion. In 2017, our products reached well over 500 million patients. Sandoz is headquartered in Holzkirchen, in Germany's Greater Munich area.